147 related articles for article (PubMed ID: 1785204)
1. Malaria infection impairs glucuronidation and biliary excretion by the isolated perfused rat liver.
Murdoch RT; Ghabrial H; Mihaly GW; Morgan DJ; Smallwood RA
Xenobiotica; 1991 Dec; 21(12):1571-82. PubMed ID: 1785204
[TBL] [Abstract][Full Text] [Related]
2. Effect of malaria on phenol conjugation pathways in perfused rat liver.
Murdoch RT; Ghabrial H; Smallwood RA; Morgan DJ
Biochem Pharmacol; 1992 Mar; 43(6):1229-34. PubMed ID: 1562275
[TBL] [Abstract][Full Text] [Related]
3. Extrahepatic sulfation and glucuronidation in the rat in vivo. Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation.
Mulder GJ; Weitering JG; Scholtens E; Dawson JR; Pang KS
Biochem Pharmacol; 1984 Oct; 33(19):3081-7. PubMed ID: 6487358
[TBL] [Abstract][Full Text] [Related]
4. Secretion of the organic anion harmol sulfate from liver into blood. Evidence for a carrier-mediated mechanism.
de Vries MH; Groothuis GM; Mulder GJ; Nguyen H; Meijer DK
Biochem Pharmacol; 1985 Jun; 34(12):2129-35. PubMed ID: 4004931
[TBL] [Abstract][Full Text] [Related]
5. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide).
Vore M; Durham S; Yeh S; Ganguly T
Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of sulfation and glucuronidation of harmol in the perfused rat liver preparation. Disappearance of aberrances in glucuronidation kinetics by inhibition of sulfation.
Koster H; Halsema I; Scholtens E; Pang KS; Mulder GJ
Biochem Pharmacol; 1982 Oct; 31(19):3023-8. PubMed ID: 7150332
[TBL] [Abstract][Full Text] [Related]
7. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
[TBL] [Abstract][Full Text] [Related]
8. Fasting increases the sensitivity of hepatic harmol glucuronidation to hypoxia.
Elliott SL; Morgan DJ; Smallwood RA
Biochem Pharmacol; 1992 Nov; 44(9):1887-90. PubMed ID: 1449541
[TBL] [Abstract][Full Text] [Related]
9. Biliary and urinary excretion of drug conjugates: effect of diuresis and choleresis on excretion of harmol sulphate and harmol glucuronide in the rat.
Jorritsma J; Meerman JH; Vonk RJ; Mulder GJ
Xenobiotica; 1979 Apr; 9(4):247-52. PubMed ID: 483860
[TBL] [Abstract][Full Text] [Related]
10. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
[TBL] [Abstract][Full Text] [Related]
11. Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate.
Krijgsheld KR; Koster HJ; Scholtens E; Mulder GJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):731-4. PubMed ID: 7086685
[TBL] [Abstract][Full Text] [Related]
12. Oxygen dependence of salbutamol elimination by the isolated perfused rat liver.
Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
Biochem Pharmacol; 1989 May; 38(9):1443-9. PubMed ID: 2719719
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of hypoxia and fasting on harmol elimination in the isolated perfused rat liver.
Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
Biochem Pharmacol; 1988 Apr; 37(7):1207-12. PubMed ID: 3355595
[TBL] [Abstract][Full Text] [Related]
14. Relation between glutathione redox changes and biliary excretion of taurocholate in perfused rat liver.
Akerboom TP; Bilzer M; Sies H
J Biol Chem; 1984 May; 259(9):5838-43. PubMed ID: 6715375
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes.
Batty KT; Ilett KF; Edwards G; Powell SM; Maggs JL; Park BK; Davis TM
Br J Pharmacol; 1998 Sep; 125(1):159-67. PubMed ID: 9776356
[TBL] [Abstract][Full Text] [Related]
16. Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.
Smallwood RH; Morgan DJ; Mihaly GW; Jones DB; Smallwood RA
J Pharmacokinet Biopharm; 1988 Aug; 16(4):377-96. PubMed ID: 3193365
[TBL] [Abstract][Full Text] [Related]
17. Decreased hepatic elimination of pyrimethamine during malaria infection. Studies in the isolated perfused rat liver.
Mihaly GW; Date NM; Veenendaal JR; Newman KT; Smallwood RA
Biochem Pharmacol; 1987 Sep; 36(17):2827-9. PubMed ID: 3307789
[TBL] [Abstract][Full Text] [Related]
18. Effect of an experimental malaria infection on the metabolism of phenacetin in the rat isolated perfused liver.
Glazier AP; Kokwaro GO; Ismail S; Edwards G
Xenobiotica; 1994 Aug; 24(8):785-93. PubMed ID: 7839701
[TBL] [Abstract][Full Text] [Related]
19. Effect of erythrocyte binding on elimination of harmol by the isolated perfused rat liver.
Morgan DJ; Guttmann A; Watson RG; Ghabrial H; Elliott SL; Smallwood RA
J Pharm Sci; 1996 Jan; 85(1):40-4. PubMed ID: 8926581
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
Wettstein M; Gerok W; Häussinger D
Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
